查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1635909

2025-2033 年按类型（活性药物成分、添加剂、成品）、服务、最终用户和地区分類的药物分析测试外包市场

Pharmaceutical Analytical Testing Outsourcing Market by Type (Active Pharmaceutical Ingredients, Additives, Finished Products), Service, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

2024年全球药物分析测试IMARC Group市场规模达90亿美元。该市场的推动因素包括人们对脂质体、奈米粒子和微球等新型药物传递系统的日益关注，癌症、糖尿病和心血管疾病等慢性疾病盛行率的增加，以及对药物开发的日益重视。

药品分析测试外包是製药业使用的测试活动，透过将部分工作外包给第三方来最大限度地降低内部生产成本。作为合约研究组织的延伸，药物分析测试外包服务已经开始取代很大一部分内部分析开发和测试。作为药物和疗法开发过程的一部分，药物测试从一开始到产品商业化都发挥着至关重要的作用。它需要确定化学品的结构、纯化物质混合物以及合成和表征活性药物成分 (API)。该计划通常涉及配方开发和早期製造，以加速复合活动。

药物分析测试外包市场趋势：

该市场的主要推动力是製药公司、合约研究组织和生物技术公司越来越多地采用外包实践。这可以归因于各个监管机构对药物开发端到端过程的分析资讯的需求不断增加。此外，不断的技术进步以及对缩短产品生命週期的关注导致新产品的快速开发，这为市场提供了动力。对产品安全和品质的需求不断增长、体内和体外测试法规的变化以及对客製化护理的日益重视也对市场产生了积极影响。组合产品、生物相似药和其他创新药物的开发导致了特定类型测试和特殊产品製造的引入，进一步推动了市场的发展。对该市场做出贡献的其他一些因素包括製药业的众多创新、外包的定价优势、为开发可持续药物而进行的广泛研究和开发(R&D)、多个国家政府的有利倡议以及越来越多的临床试验註册。

本报告回答的关键问题：

  • 全球药物分析测试外包市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对全球药物分析测试外包市场有何影响？
  • 主要区域市场有哪些？
  • 依类型划分市场是怎么样的？
  • 基于服务的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球药品分析测试外包市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药物分析测试外包市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 活性药物成分 (API)
    • 市场趋势
    • 市场预测
  • 添加剂
    • 市场趋势
    • 市场预测
  • 製成品
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按服务

  • 生物分析测试
    • 市场趋势
    • 关键参与者
      • 临床
      • 非临床
    • 市场预测
  • 方法开发和验证
    • 市场趋势
    • 关键参与者
      • 可萃取和可浸出
      • 杂质法
      • 技术咨询
      • 其他的
    • 市场预测
  • 稳定性测试
    • 市场趋势
    • 关键参与者
      • 原料药
      • 稳定性指示方法验证
      • 加速稳定性测试
      • 光稳定性测试
      • 其他的
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 製药公司
    • 市场趋势
    • 市场预测
  • 生物製药公司
    • 市场趋势
    • 市场预测
  • 合约研究组织
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.)
    • Alcami Corporation Inc.
    • Boston Analytical Inc.
    • Catalent Inc.
    • Charles River Laboratories International Inc.
    • Eurofins Scientific SE
    • Intertek Group plc
    • Laboratory Corporation of America Holdings
    • Pace Analytical Services LLC
    • SGS SA
    • Thermo Fisher Scientific Inc.
    • West Pharmaceutical Services Inc.
    • WuXi AppTec Inc.
Product Code: SR112025A6620

The global pharmaceutical analytical testing outsourcing market size reached USD 9.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.49% during 2025-2033. The market is driven by the growing focus on new drug delivery systems, such as liposomes, nanoparticles, and microspheres, increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disease, and rising emphasis on drug development.

Pharmaceutical analytical testing outsourcing is a testing activity used in the pharmaceutical industry to minimize in-house production costs by outsourcing parts of the work to a third party. As an extension of contract research organizations, pharmaceutical analytical testing outsourcing services have begun replacing a significant portion of in-house analytical development and testing. As part of the development process for drugs and therapies, pharmaceutical testing plays a vital role from the beginning through the commercialization of the product. It entails determining the structures of chemicals, purifying a mixture of substances, and synthesizing and characterizing active medicinal ingredients (APIs). Formulation development and early-phase manufacturing are usually involved in this initiative to speed up compound activities.

Pharmaceutical Analytical Testing Outsourcing Market Trends:

The market is majorly driven by the increasing adoption of outsourcing practices in pharmaceutical companies, contract research organizations, and biotech companies. This can be attributed to the escalating demand for analytical information on the end-to-end process of drug development by various regulatory agencies. Additionally, continual technological advancements with an enhanced focus on shortening the product lifecycle have resulted in the rapid development of new products, which is providing an impetus to the market. The rising need for product safety and quality, changing regulations for in vivo and in vitro tests, and an augmented emphasis on customized care is also impacting the market positively. The development of combination products, biosimilar, and other innovative medicines leading to the introduction of specific types of tests and specialty product manufacturing are further fueling the market. Some of the other factors contributing to the market include numerous innovations in the pharmaceutical industry, the pricing benefits of outsourcing, extensive research and development (R&D) conducted to develop sustainable drugs, favorable initiatives by the governments of several countries, and the growing number of clinical trial registrations.

Key Market Segmentation:

Breakup by Type:

Active Pharmaceutical Ingredients (API)

Additives

Finished Products

Breakup by Service:

Bioanalytical Testing

Clinical

Non-Clinical

Method Development and Validation

Extractable and Leachable

Impurity Method

Technical Consulting

Others

Stability Testing

Drug Substance

Stability Indicating Method Validation

Accelerated Stability Testing

Photostability Testing

Others

Others

Breakup by End User:

Pharmaceutical Companies

Biopharmaceutical Companies

Contract Research Organizations

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.), Alcami Corporation Inc., Boston Analytical Inc., Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, SGS S.A., Thermo Fisher Scientific Inc., West Pharmaceutical Services Inc. and WuXi AppTec Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

The global pharmaceutical analytical testing outsourcing market size reached USD 9.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.49% during 2025-2033. The market is driven by the growing focus on new drug delivery systems, such as liposomes, nanoparticles, and microspheres, increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disease, and rising emphasis on drug development.

Pharmaceutical analytical testing outsourcing is a testing activity used in the pharmaceutical industry to minimize in-house production costs by outsourcing parts of the work to a third party. As an extension of contract research organizations, pharmaceutical analytical testing outsourcing services have begun replacing a significant portion of in-house analytical development and testing. As part of the development process for drugs and therapies, pharmaceutical testing plays a vital role from the beginning through the commercialization of the product. It entails determining the structures of chemicals, purifying a mixture of substances, and synthesizing and characterizing active medicinal ingredients (APIs). Formulation development and early-phase manufacturing are usually involved in this initiative to speed up compound activities.

Pharmaceutical Analytical Testing Outsourcing Market Trends:

The market is majorly driven by the increasing adoption of outsourcing practices in pharmaceutical companies, contract research organizations, and biotech companies. This can be attributed to the escalating demand for analytical information on the end-to-end process of drug development by various regulatory agencies. Additionally, continual technological advancements with an enhanced focus on shortening the product lifecycle have resulted in the rapid development of new products, which is providing an impetus to the market. The rising need for product safety and quality, changing regulations for in vivo and in vitro tests, and an augmented emphasis on customized care is also impacting the market positively. The development of combination products, biosimilar, and other innovative medicines leading to the introduction of specific types of tests and specialty product manufacturing are further fueling the market. Some of the other factors contributing to the market include numerous innovations in the pharmaceutical industry, the pricing benefits of outsourcing, extensive research and development (R&D) conducted to develop sustainable drugs, favorable initiatives by the governments of several countries, and the growing number of clinical trial registrations.

Key Market Segmentation:

Breakup by Type:

Active Pharmaceutical Ingredients (API)

Additives

Finished Products

Breakup by Service:

Bioanalytical Testing

Clinical

Non-Clinical

Method Development and Validation

Extractable and Leachable

Impurity Method

Technical Consulting

Others

Stability Testing

Drug Substance

Stability Indicating Method Validation

Accelerated Stability Testing

Photostability Testing

Others

Others

Breakup by End User:

Pharmaceutical Companies

Biopharmaceutical Companies

Contract Research Organizations

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.), Alcami Corporation Inc., Boston Analytical Inc., Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, SGS S.A., Thermo Fisher Scientific Inc., West Pharmaceutical Services Inc. and WuXi AppTec Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global pharmaceutical analytical testing outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical analytical testing outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the service?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical analytical testing outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Analytical Testing Outsourcing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Active Pharmaceutical Ingredients (API)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Additives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Finished Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Service

  • 7.1 Bioanalytical Testing
    • 7.1.1 Market Trends
    • 7.1.2 Key Players
      • 7.1.2.1 Clinical
      • 7.1.2.2 Non-Clinical
    • 7.1.3 Market Forecast
  • 7.2 Method Development and Validation
    • 7.2.1 Market Trends
    • 7.2.2 Key Players
      • 7.2.2.1 Extractable and Leachable
      • 7.2.2.2 Impurity Method
      • 7.2.2.3 Technical Consulting
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast
  • 7.3 Stability Testing
    • 7.3.1 Market Trends
    • 7.3.2 Key Players
      • 7.3.2.1 Drug Substance
      • 7.3.2.2 Stability Indicating Method Validation
      • 7.3.2.3 Accelerated Stability Testing
      • 7.3.2.4 Photostability Testing
      • 7.3.2.5 Others
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Biopharmaceutical Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alcami Corporation Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Boston Analytical Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Catalent Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Charles River Laboratories International Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Eurofins Scientific SE
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Intertek Group plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Laboratory Corporation of America Holdings
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pace Analytical Services LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 SGS S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 West Pharmaceutical Services Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 WuXi AppTec Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Pharmaceutical Analytical Testing Outsourcing Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Service (in %), 2024
  • Figure 6: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Pharmaceutical Analytical Testing Outsourcing (Active Pharmaceutical Ingredients (API)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Pharmaceutical Analytical Testing Outsourcing (Active Pharmaceutical Ingredients (API)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Pharmaceutical Analytical Testing Outsourcing (Additives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Pharmaceutical Analytical Testing Outsourcing (Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Pharmaceutical Analytical Testing Outsourcing (Finished Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Pharmaceutical Analytical Testing Outsourcing (Finished Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Pharmaceutical Analytical Testing Outsourcing (Bioanalytical Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Pharmaceutical Analytical Testing Outsourcing (Bioanalytical Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Pharmaceutical Analytical Testing Outsourcing (Method Development and Validation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Pharmaceutical Analytical Testing Outsourcing (Method Development and Validation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Pharmaceutical Analytical Testing Outsourcing (Stability Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Pharmaceutical Analytical Testing Outsourcing (Stability Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Pharmaceutical Analytical Testing Outsourcing (Other Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Pharmaceutical Analytical Testing Outsourcing (Other Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Pharmaceutical Analytical Testing Outsourcing (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Pharmaceutical Analytical Testing Outsourcing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Pharmaceutical Analytical Testing Outsourcing (Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Pharmaceutical Analytical Testing Outsourcing (Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Pharmaceutical Analytical Testing Outsourcing (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Pharmaceutical Analytical Testing Outsourcing (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Pharmaceutical Analytical Testing Outsourcing Industry: SWOT Analysis
  • Figure 78: Global: Pharmaceutical Analytical Testing Outsourcing Industry: Value Chain Analysis
  • Figure 79: Global: Pharmaceutical Analytical Testing Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Analytical Testing Outsourcing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Service (in Million USD), 2025-2033
  • Table 4: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Pharmaceutical Analytical Testing Outsourcing Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Analytical Testing Outsourcing Market: Key Players